Kobo Biotech Ltd-$ share price
BSE: 531541Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹4.11.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9.77 Cr4,799th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 7,436
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the year to Mar 2016.Quarterly results
Quarter to Jun 2024, against the quarter beforeFiled 21 Aug
- RevenueRevenue. Under it, revenue in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.00 CrQuarter to Mar 2024: ₹0.00 Cr
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹1.33 CrQuarter to Mar 2024: −₹1.26 Cr
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Sep 2022Filed 25 Nov | Dec 2022Filed 16 Feb | Mar 2023Filed 30 May | Jun 2023Filed 11 Aug | Sep 2023Filed 28 Nov | Dec 2023Filed 26 Feb | Mar 2024Filed 2 Jul | Jun 2024Filed 21 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | −1.10 | −1.19 | −1.79 | −1.23 | −1.22 | −1.23 | −1.26 | −1.33 |
Business segments
In the year to Mar 2024 the company reports one business segment, Manufacturing Active Pharmaceutical Ingredients (API)/ Bulk Drugs, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2024, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +100.0% | – | – | 0.0% |
| 3 years | −19.9% | – | – | 0.0% |
| 5 years | −3.7% | – | – | 0.0% |
Peers and competitors
Commodity Chemicals, 74 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Kobo Biotech Ltd-$ in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Kobo Biotech Ltd-$ is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 16 | 20.6 | 1.0 | 5.7 | +52.3% | +71.9% | 4.9% | 9.1% | 0.00% | |
| 11 | – | 0.8 | 13.8 | +16.3% | – | −0.1% | 1.2% | 0.00% | |
| 11 | 26.5 | 1.3 | – | −46.0% | −0.6% | 5.0% | −18.8% | 0.00% | |
| 10 | – | 0.7 | 35.9 | −15.5% | – | – | −1.1% | 0.00% | |
| 10 | – | 0.5 | – | +34.8% | – | – | −6.2% | 0.00% | |
| 8 | – | 4.5 | – | +35.5% | – | – | −3.0% | 0.00% | |
| 8 | 2.7 | 1.1 | – | −34.4% | – | 53.0% | −17.2% | 0.00% | |
| 7 | 85.6 | 0.2 | 61.7 | −22.2% | −52.3% | 0.4% | 0.3% | 0.00% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
| Ex-date | Type | Per share |
|---|---|---|
| 21 Sep 2012 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 22 Jul 2011 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 23 Sep 2010 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
Latest announcements
Routine notices left out.Share news and announcements
Jul 2026
16 Jul · Update On Implementation Of Approved Resolution Plan Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jun 2026
26 Jun · Meeting
Kobo Biotech Ltd-$ share price by year
Each calendar year to 2025.Kobo Biotech Ltd-$ share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 2.39 | −44.9% | 4.13 | 2.09 |
| 2024 | 4.34 | +40.0% | 5.73 | 2.74 |
| 2023 | 3.10 | −16.7% | 4.29 | 1.90 |
| 2022 | 3.72 | −64.0% | 11.32 | 3.48 |
| 2021 | 10.33 | +18.3% | 10.33 | 3.51 |
| 2020 | 8.73 | +164.5% | 10.29 | 1.90 |
| 2019 | 3.30 | −52.8% | 7.00 | 1.25 |
| 2018 | 6.99 | −50.9% | 20.26 | 4.60 |
| 2017 | 14.25 | +24.7% | 14.25 | 4.45 |
| 2016 | 11.43 | −70.4% | 43.30 | 6.61 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 | 7,436 |
| 22 Oct 2026 | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 | 2,563 |
| 21 Oct 2026 | 4.19 | 4.19 | 4.19 | 4.19 | 4.19 | 4,111 |
| 19 Oct 2026 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 110 |
| 16 Oct 2026 | 4.35 | 4.36 | 4.35 | 4.35 | 4.35 | 9,716 |
| 15 Oct 2026 | 4.43 | 4.47 | 4.43 | 4.43 | 4.43 | 6,970 |
| 14 Oct 2026 | 4.52 | 4.70 | 4.52 | 4.52 | 4.56 | 6,316 |
| 13 Oct 2026 | 4.59 | 5.04 | 4.59 | 4.61 | 5.00 | 11,399 |
| 12 Oct 2026 | 4.81 | 4.81 | 4.59 | 4.80 | 4.80 | 18,394 |
| 9 Oct 2026 | 4.59 | 4.59 | 4.40 | 4.59 | 4.58 | 81,160 |
Company details
- Legal name
- KOBO BIOTECH LIMITED
- BSE code
- 531541
- ISIN
- INE881A01015
- Industry
- Chemicals & Petrochemicals
- Listed
- Mar 2000
- Face value
- ₹10
- CIN
- L24110TG1993PLC016112
- Corporate identity number, the registrar of companies' code for it